Search Legislation

The Genetically Modified Organisms (Contained Use) Regulations (Northern Ireland) 2015

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Regulation 2(1)

SCHEDULE 1Classes of contained use

ClassDescription
1Contained use of no or negligible risk, for which containment level 1 is appropriate to protect human health and the environment.
2Contained use of low risk, for which containment level 2 is appropriate to protect human health and the environment.
3Contained use of moderate risk, for which containment level 3 is appropriate to protect human health and the environment.
4Contained use of high risk, for which containment level 4 is appropriate to protect human health and the environment.

Regulation 2(1) and 3(1)

SCHEDULE 2

PART 1Techniques constituting genetic modification

1.  The techniques which constitute genetic modification referred to in sub-paragraph (a) of the definition of “genetic modification” in regulation 2(1) are—

(a)recombinant nucleic acid techniques involving the formation of new combinations of genetic material by the insertion of nucleic acid molecules, produced by whatever means outside an organism, into any virus, bacterial plasmid or other vector system and their incorporation into a host organism in which they do not naturally occur but in which they are capable of continued propagation;

(b)techniques involving the direct introduction into an organism of heritable genetic material prepared outside the organism, including micro-injection, macro-injection and micro-encapsulation;

(c)cell fusion or hybridization techniques where live cells with new combinations of heritable genetic material are formed through the fusion of two or more cells by means of methods that do not occur naturally.

PART 2Techniques which are not considered to result in genetic modification

2.  The following techniques are not considered to result in genetic modification provided that they do not involve the use of recombinant nucleic acid molecules or of genetically modified organisms made by techniques other than those listed in Part 3—

(a)in vitro fertilisation;

(b)natural processes including conjugation, transduction or transformation;

(c)polyploidy induction.

PART 3Techniques to which these Regulations do not apply

3.  These Regulations (except regulation 18) shall not apply to the following techniques of genetic modification, provided that they do not involve the use of recombinant nucleic acid molecules or of genetically modified organisms other than those made by one or more of the following techniques—

(a)mutagenesis;

(b)cell fusion (including protoplast fusion) of prokaryotic species which can exchange genetic material through homologous recombination;

(c)cell fusion (including protoplast fusion) of cells of any eukaryotic species, including production of hybridomas and plant cell fusions;

(d)self-cloning, where the resulting organism is unlikely to cause disease or harm to humans, animals or plants.

4.  In paragraph 3—

(a)“self-cloning” means the removal of nucleic acid sequences from a cell of an organism which may or may not be followed by reinsertion of all or part of that nucleic acid (or a synthetic equivalent), whether or not altered by enzymic or mechanical processes, into cells of the same species or into cells of phylogenetically closely related species which can exchange genetic material by homologous recombination; and

(b)self-cloning may include the use of recombinant vectors, with an extended history of safe use in the particular organism, to manipulate and reinsert the nucleic acid sequences, but the vectors shall not consist of any genetic elements other than those designed for vector structure, vector replication, vector maintenance or marker genes.

Regulations 2(3), 3(4) and 5

SCHEDULE 3

PART 1Matters to be taken into account in carrying out an assessment for the purposes of regulation 5

1.  The following matters shall be taken into account in carrying out an assessment for the purposes of regulation 5—

(a)any potentially harmful effects, in particular those associated with—

(i)the recipient micro-organism;

(ii)the inserted genetic material (originating from the donor organism);

(iii)the vector;

(iv)the donor micro-organism (where that donor micro-organism is used during the contained use);

(v)the resulting genetically modified micro-organism;

(b)the characteristics of the contained use;

(c)the severity of the potentially harmful effects;

(d)the likelihood of the potentially harmful effects being realised;

(e)the disposal of waste and effluents.

2.  In paragraph 1, “potentially harmful effects” includes—

(a)disease to humans including allergenic or toxic effects;

(b)disease to animals or plants;

(c)adverse effects resulting from the inability to treat disease or offer an effective prophylaxis;

(d)adverse effects resulting from establishment or dissemination of the genetically modified micro-organisms in the environment;

(e)adverse effects resulting from the natural transfer of genetic material to or from other organisms;

(f)adverse effects resulting from the likely interaction of the genetically modified micro-organism with other organisms at the premises where the contained use is to be conducted.

PART 2Steps to be included when carrying out an assessment for the purposes of regulation 5

3.  An assessment carried out for the purposes of regulation 5 shall include—

(a)identification of any harmful properties of the recipient and, where appropriate, the donor micro-organism;

(b)identification of any harmful properties associated with the vector or inserted material, including any alteration in the existing properties of the recipient;

(c)recognition that, in general, only contained use which shows the following characteristics is appropriate for inclusion in class 1 as described in Schedule 1—

(i)the recipient or parental micro-organism is unlikely to cause disease to humans, animals or plants;

(ii)the nature of the vector and the insert is such that they do not endow the genetically modified micro-organism with a phenotype likely to cause disease to humans, animals or plants, or likely to cause deleterious effects on the environment; and

(iii)the genetically modified micro-organism is unlikely to cause disease to humans, animals or plants and is unlikely to have deleterious effects on the environment;

(d)consideration of relevant EU legislation, including Directive (EC) No 2000/54 of the European Parliament and the Council on the protection of workers from risks related to exposure to biological agents at work(1), other classification schemes referring to plant and animal pathogens, and other international and national classification schemes for genetically modified micro-organisms;

(e)identification of the provisional level of risk associated with the genetically modified micro-organism;

(f)consideration of—

(i)the characteristics of the environment likely to be exposed;

(ii)the characteristics of the contained use involving micro-organisms;

(iii)any contained use of micro-organisms which cannot be controlled adequately by standard laboratory procedures, and which presents risks which require controls for each individual case;

(g)adjustment of the provisional level of risk in the light of the matters referred to in sub-paragraph (f);

(h)selection of the appropriate containment measures from those specified in the applicable table in Schedule 8 on the basis of the provisional level of risk as adjusted in accordance with sub-paragraph (g);

(i)assignment of the contained use to the appropriate containment level, in accordance with paragraph 4;

(j)classification of the contained use in the class of the same number as that of the appropriate containment level;

(k)review and reconsideration of that classification in the light of the completed risk assessment.

4.  To assign a contained use to the appropriate containment level for the purposes of paragraph 3(i), the person carrying out the risk assessment shall—

(a)first identify for each selected containment measure the column in the applicable table in Schedule 8 having the lowest number in which that selected containment measure is shown as being required, regardless of whether or not such requirement is subject to any qualification;

(b)then select the highest number of all the columns identified in accordance with sub-paragraph (a); and

(c)then assign the contained use to the containment level of that highest number.

5.  In paragraph 4, “selected containment measure” means an appropriate containment measure selected in accordance with paragraph 3(h).

Regulation 6

SCHEDULE 4

PART 1Matters to be taken into account in carrying out an assessment for the purposes of regulation 6

1.  The following matters shall be taken into account in carrying out an assessment for the purposes of regulation 6—

(a)any potentially harmful effects, in particular those associated with—

(i)the recipient organism;

(ii)the inserted genetic material (originating from the donor organism);

(iii)the vector;

(iv)the donor organism;

(v)the resulting genetically modified organism;

(b)the characteristics of the contained use;

(c)the severity of the potentially harmful effects;

(d)the likelihood of the potentially harmful effects being realised.

2.  In paragraph 1, “potentially harmful effects” includes—

(a)disease to humans including allergenic or toxic effects;

(b)acting as a human disease vector or reservoir;

(c)adverse effects to humans arising from change in behaviour or in physical nature;

(d)adverse effects arising from the inability to treat human disease or offer effective prophylaxis.

PART 2Steps to be included when carrying out an assessment for the purposes of regulation 6

3.  An assessment carried out for the purposes of regulation 6 shall include—

(a)identification of any harmful properties of the recipient and, where appropriate, the donor organism;

(b)identification of any harmful properties associated with the vector or inserted material, including any alteration in the existing properties of the recipient;

(c)identification of the provisional level of risk associated with the genetically modified organisms;

(d)selection of containment and other protective measures on the basis of—

(i)the provisional level of risk; and

(ii)the characteristics of the contained use;

(e)adjustment of the level of risk in the light of the matters referred to in sub-paragraph (d);

(f)review and reconsideration of the containment and other protective measures in the light of the steps required by sub-paragraphs (a) to (e).

Regulations 9(2), 14(1) and 28(3)

SCHEDULE 5Information required for a notification under regulation 9(2)

A notification required for the purposes of regulation 9(2) shall contain the following information—

(a)the name, address and telephone number and any fax number and any e-mail address of the notifier;

(b)the name of the person with specific responsibility for the supervision and safety of contained use;

(c)information on the training and qualifications of that person;

(d)details of the arrangements for obtaining advice on risk assessments in accordance with regulation 8, including details of any genetic modification safety committee if established;

(e)the address of the premises where the contained use is to be carried out and a general description of the premises, together with, if required by regulation 9(6), the principal address of premises;

(f)the nature of the work to be undertaken;

(g)the class of any contained use involving micro-organisms;

(h)where the first contained use to be carried out in those premises is a class 1 contained use—

(i)a summary of the risk assessment of that contained use;

(ii)any advice received in relation to the risk assessment from a person or genetic modification safety committee in accordance with regulation 8;

(iii)information on waste management;

(iv)confirmation that the emergency services, and any body or authority liable to be affected by an accident to which any emergency plan relates, will be informed of the contents of the emergency plan and of any relevant revisions;

(i)where the first contained use to be carried out in those premises is a contained use involving larger GMOs and that contained use is not notifiable under regulation 12(2)—

(i)a copy of the risk assessment; and

(ii)confirmation that the emergency services, and any body or authority liable to be affected by an accident to which any emergency plan relates, will be informed of the contents of the emergency plan and of any relevant revisions.

Regulations 10(2), 11(2), 12(2), 14(1), 28(3) and 33(6)

SCHEDULE 6Information required for a notification under regulations 10(2), 11(2) or 12(2)

A notification required for the purposes of regulation 10(2), 11(2) or 12(2) shall contain the following information except where it is required only for a specified regulation—

(a)the name, address and telephone number and any fax number and any e-mail address of the notifier;

(b)any centre number allocated by the competent authority in respect of the premises at which the contained use is to be undertaken and the date of the notification required by regulation 9(2) relating to those premises;

(c)the name of the person with specific responsibility for supervision and safety of contained use;

(d)information on the training and qualifications of that person;

(e)the recipient or parental micro-organism to be used;

(f)the donor micro-organism to be used;

(g)where applicable, the host-vector system to be used;

(h)the source and intended function of the genetic material involved in the modification;

(i)the identity and characteristics of the genetically modified organism;

(j)the purpose of the contained use, including its expected results;

(k)for regulation 10(2) the approximate culture volumes to be used;

(l)for regulation 11(2) the culture volumes to be used;

(m)a description of the containment and other protective measures to be applied, including—

(i)information on waste management, including the type and form of wastes to be generated, their treatment, ultimate form and destination; and

(ii)for regulation 10(2) justification for not applying any containment measure at containment level 2;

(iii)for regulation 11(2), for class 3 contained use, justification for not applying any containment measure at containment level 3;

(iv)for regulation 11(2), for class 4 contained use, justification for not applying any containment measure at containment level 4;

(n)for regulations 10(2) and 11(2) a copy of the risk assessment;

(o)for regulations 10(2) and 11(2) the advice received in relation to that assessment from a genetic modification safety committee;

(p)for regulation 12(2) a copy of the risk assessment;

(q)information in relation to any accident prevention and emergency plans including—

(i)the information necessary for the competent authority to evaluate any emergency plan;

(ii)confirmation that the emergency services, and any body or authority liable to be affected by an accident to which any emergency plan relates, will be informed of the contents of the emergency plan and of any relevant revisions;

(iii)for regulation 11(2), in addition—

(aa)any specific hazards arising from the location of the installation;

(bb)the preventive measures applied, including safety equipment, alarm systems and containment methods;

(cc)procedures and plans for verifying the continuing effectiveness of the containment measures;

(dd)a description of the information provided to workers;

(r)for regulation 11(2) a description of the parts of the installation;

(s)for regulation 11(2) whether the genetically modified organism is likely to be subject to transboundary movement.

Regulation 18

SCHEDULE 7General principles of good microbiological practice and of good occupational safety and hygiene

The general principles of good microbiological practice and of good occupational safety and hygiene are as follows—

(a)keeping workplace and environmental exposure to any genetically modified micro-organism to the lowest reasonably practicable level;

(b)exercising engineering control measures at source and supplementing these with appropriate personal protective clothing and equipment where necessary;

(c)testing adequately and maintaining control measures and equipment;

(d)testing, where necessary, for the presence of viable process organisms outside the primary physical containment;

(e)providing appropriate training of personnel;

(f)establishing a genetic modification safety committee, if required;

(g)formulating and implementing local codes of practice for the safety of personnel, as required;

(h)displaying biohazard signs where appropriate;

(i)providing washing and decontamination facilities for personnel;

(j)keeping adequate records;

(k)prohibiting in the work area eating, drinking, smoking, applying cosmetics or the storing of food for human consumption;

(l)prohibiting mouth pipetting;

(m)providing written standard operating procedures where appropriate to ensure safety;

(n)having effective disinfectants and specified disinfection procedures available in case of spillage of genetically modified micro-organisms;

(o)providing safe storage for contaminated laboratory equipment and materials where appropriate.

Regulations 2(2) and 19(1)

SCHEDULE 8

PART 1General

1.  In this Schedule—

“GMMs” means genetically modified micro-organisms;

HEPA” means High Efficiency Particulate Air;

“inactivation” means the complete or partial destruction of GMMs so as to ensure that any contact between the GMMs and humans or the environment is limited to an extent commensurate with the risks identified in the risk assessment and to provide a high level of protection for humans and the environment;

“plant growth facilities” means a structure, whether permanent or impermanent, designed and used principally for growing plants in a controlled and protected environment.

2.  For the purposes of this Schedule where in the final column of Table 1b or 1c, a measure is specified as—

(a)a modification, it is to be read in substitution for the relevant measure in Table 1a;

(b)additional, it is to be read as an addition to the measures in Table 1a, and any measure which has been substituted for a measure in Table 1a, in accordance with paragraph 2(a).

3.  For the purposes of this Schedule—

(a)Table 1a describes containment measures applicable to contained use involving micro-organisms in laboratories;

(b)Table 1a, read with Table 1b, describes containment measures applicable to contained use involving micro-organisms in plant growth facilities;

(c)Table 1a, read with Table 1c, describes containment measures applicable to contained use involving micro-organisms in animal units;

(d)Table 2 describes containment measures applicable to contained use involving micro-organisms in premises other than those referred to in Tables 1a, 1b and 1c.

PART 2Containment measures

Table 1a

Containment measures applicable to contained use involving micro-organisms in laboratories

Containment MeasuresContainment Levels
1234
(1)

“isolation” means, in relation to a laboratory, separation of the laboratory from other areas in the same building, or being in a separate building.

(2)

Entry must be through an airlock which is a chamber isolated from the laboratory. The clean side of the airlock must be separated from the restricted side by changing or showering facilities and preferably by interlocking doors.

(3)

Where viruses are not retained by the HEPA filters, extra requirements will be necessary for extract air.

(4)

Where the autoclave is outside the laboratory in which the contained use is being undertaken, but within the laboratory suite, there must be validated procedures for the safe transfer of material into that autoclave, which provide a level of protection equivalent to that which would be achieved by having an autoclave in that laboratory.

Facilities
1Laboratory suite: isolation(1)not requirednot requiredrequiredrequired
2Laboratory: sealable for fumigationnot requirednot requiredrequiredrequired
Equipment
3Surfaces impervious to water, resistant to acids, alkalis, solvents, disinfectants and decontam-ination agents and easy to cleanrequired for any benchrequired for any benchrequired for any bench and floorrequired for any bench, floor, ceiling and walls
4Entry to laboratory via airlock(2)not requirednot requiredrequired where and to extent the risk assessment shows it is requiredrequired
5Negative pressure relative to the pressure of the immediate surroundingsnot requirednot requiredrequired except for activities where transmission does not occur by the airborne routerequired
6Extract and input air from the laboratory must be HEPA filterednot requirednot requiredHEPA filters required for extract air except for activities where transmission does not occur by the airborne routeHEPA filters required for input and extract air(3)
7Micro-biological safety cabinet /enclosurenot requiredrequired where and to extent the risk assessment shows it is requiredrequired, and all procedures with infective materials required to be contained within a cabinet/ enclosure

required,

and all procedures with infective materials required to be contained within a cabinet/

enclosure

8Autoclaverequired on siterequired in the buildingrequired in the laboratory suite(4)double ended autoclave required in laboratory
System of work
9Access restricted to authorised personnel onlynot requiredrequiredrequiredrequired (via airlock key procedure)
10Biohazard sign on doornot requiredrequiredrequiredrequired
11Specific measures to control aerosol dissem-inationnot requiredrequired so as to minimiserequired so as to preventrequired so as to prevent
12Showernot requirednot requiredrequired where and to extent the risk assessment shows it is requiredrequired
13Protective clothingsuitable protective clothing requiredsuitable protective clothing requiredsuitable protective clothing required; footwear required where and to extent the risk assessment shows it is requiredcomplete change of clothing and footwear required before entry and exit
14Glovesnot requiredrequired where and to extent the risk assessment shows they are requiredrequiredrequired
15Efficient control of disease vectors (e.g. rodents and insects) which could disseminate GMMsrequired where and to extent the risk assessment shows it is requiredrequiredrequiredrequired
Waste
16Inactivation of GMMs in effluent from hand-washing sinks and showers and similar effluentsnot requirednot requiredrequired where and to extent the risk assessment shows it is requiredrequired
17Inactivation of GMMs in contaminated material and wasterequired by validated means where and to extent the risk assessment shows it is requiredrequired by validated meansrequired by validated means, with waste inactivated within the laboratory suiterequired by validated means, with waste inactivated within the laboratory
Other measures
18Laboratory to contain its own equipmentnot requirednot requiredrequired, so far as is reasonably practicablerequired
19An observation window or alternative is to be present so that occupants can be seenrequired where and to extent the risk assessment shows it is requiredrequired where and to extent the risk assessment shows it is requiredrequired where and to extent the risk assessment shows it is requiredrequired
20Safe storage of GMMsrequired where and to extent the risk assessment shows it is requiredrequiredrequiredsecure storage required
21Written records of staff trainingnot requiredrequired where and to extent the risk assessment shows it is requiredrequiredrequired

Table 1b

Containment measures applicable to contained use involving micro-organisms in plant growth facilities (to be read with Table 1a as indicated in paragraph 3(b) of Part 1)

Containment MeasuresContainment LevelsAdditional/ modification
1234
(1)

A permanent structure refers to a fixed structure with walls, a roof and a floor. Where the permanent structure is a greenhouse, that structure shall also have a continuous waterproof covering and self-closing lockable outer doors, and be located on a site designed to prevent the entry of surface run-off water.

Facilities
1Permanent structure(1)required where and to extent the risk assessment shows it is requiredrequiredrequiredrequiredmodification
Equipment
2Entry via a separate room with two interlocking doorsnot requiredrequired where and to extent the risk assessment shows it is requiredrequired where and to extent the risk assessment shows it is requiredrequired (via airlock key procedure)additional
3Control of contaminated run-off waterrequired where and to extent the risk assessment shows it is requiredrequired so as to minimise run-offrequired so as to prevent run-offrequired so as to prevent run-offadditional
System of work
4Effective control of disease vectors such as insects, rodents and arthropods which could disseminate GMMsrequiredrequiredrequiredrequiredadditional
5Effective control of pollen, seeds and other plant material which could disseminate GMMsrequired where and to extent the risk assessment shows it is requiredrequired so as to minimise dissem-inationrequired so as to prevent dissem-inationrequired so as to prevent dissem-inationadditional
6Procedures for transfer of living material between the plant growth facilities, protective structure and laboratory shall control dissemination of GMMsrequired so as to minimise dissem-inationrequired so as to minimise dissem-inationrequired so as to prevent dissem-inationrequired so as to prevent dissem-inationadditional

Table 1c

Containment measures applicable to contained use involving micro-organisms in animal units (to be read with Table 1a as indicated in paragraph 3(c))

Containment MeasuresContainment LevelsAdditional/ modification
1234
(1)

“animal unit” means a building, or separate area within a building, containing an animal facility and other areas including changing rooms, showers, autoclaves and food storage areas.

(2)

“animal facility” means a facility normally used to house stock, breeding or experimental animals or one which is used for the performance of minor surgical procedures on animals.

(3)

“isolators” means transparent boxes where small animals are contained within or outside a cage; for large animals, isolated rooms may be more appropriate.

Facilities
1Isolation of animal unit(1)required where and to extent the risk assessment shows it is requiredrequiredrequiredrequiredmodification
2Animal facilities(2) separated by lockable doorsrequired where and to extent the risk assessment shows it is requiredrequiredrequiredrequiredadditional
3Animal facilities (cages, etc.) designed to facilitate decontamin-ation (waterproof and easily washable material)required where and to extent the risk assessment shows it is requiredrequired where and to extent the risk assessment shows it is requiredrequiredrequiredadditional
4Floor, walls and ceiling easily washablerequired where and to extent the risk assessment shows it is requiredrequired for floorrequired for floor and wallsrequired for floor, walls and ceilingmodification
5Appropriate filters on isolators or isolated rooms(3)not requiredrequired where and to extent the risk assessment shows it is requiredrequiredrequiredadditional
6Appropriate barriers at the room exit, and at drains or ventilation duct workrequiredrequiredrequiredrequiredadditional
7Animals kept in appropriate containment facilities, such as cages, pens or tanks but not isolatorsrequired where and to extent the risk assessment shows it is requiredrequired where and to extent the risk assessment shows it is requiredrequired where and to extent the risk assessment shows it is requiredrequired where and to extent the risk assessment shows it is requiredadditional
8Animals kept in isolatorsnot requiredrequired where and to extent the risk assessment shows it is requiredrequiredrequiredmodification

Table 2

Containment measures applicable to contained use involving micro-organisms in premises other than those referred to in Tables 1a, 1b and 1c

Containment MeasuresContainment Levels
1234
General
1Viable micro-organisms shall be contained in a system which separates the process from the workplace and wider environment (closed system)required where and to extent the risk assessment shows it is requiredrequiredrequiredrequired
2Closed systems located within a controlled areanot requiredrequired where and to extent the risk assessment shows it is requiredrequiredrequired
3Control of exhaust gases from the closed systemnot requiredrequired so as to minimise releaserequired so as to prevent releaserequired so as to prevent release
4Control of aerosols during sample collection, addition of material to a closed system or transfer of material to another closed systemrequired where and to extent the risk assessment shows it is requiredrequired so as to minimise releaserequired so as to prevent releaserequired so as to prevent release
5Inactivation of bulk culture fluids before removal from the closed systemrequired where and to extent the risk assessment shows it is requiredrequired by validated meansrequired by validated meansrequired by validated means
6Seals shall be designed so as to minimise or prevent releasenot requiredrequired so as to minimise releaserequired so as to prevent releaserequired so as to prevent release
7The controlled area designed to contain spillage of the entire contents of the closed systemrequired where and to extent the risk assessment shows it is requiredrequired where and to extent the risk assessment shows it is requiredrequiredrequired
8The controlled area sealable to permit fumigationnot requiredrequired where and to extent the risk assessment shows it is requiredrequired where and to extent the risk assessment shows it is requiredrequired
9Biohazard signs postednot requiredrequiredrequiredrequired
Equipment
10Entry via airlocknot requirednot requiredrequired where and to extent the risk assessment shows it is requiredrequired
11Surfaces resistant to water, acids, alkalis, solvents, disinfectants and decontamination agents and easy to cleanrequired for any benchrequired for any benchrequired for any bench and floorrequired for any bench, floor, ceilings and walls
12Specific measures to ventilate adequately the controlled areas in order to minimise air contaminationrequired where and to extent the risk assessment shows they are requiredrequired where and to extent the risk assessment shows they are requiredrequired where and to extent the risk assessment shows they are requiredrequired
13The controlled area maintained at an air pressure negative to the immediate surroundingsnot requirednot requiredrequired where and to extent the risk assessment shows it is requiredrequired
14Extract and input air from the controlled area must be HEPA filterednot requirednot requiredrequired for extract air; required where and to extent the risk assessment shows they are required for input airrequired for input and extract air
System of work
15Access restricted to authorised personnel onlynot requiredrequiredrequiredrequired
16Personnel must shower before leaving the controlled areanot requirednot requiredrequired where and to extent the risk assessment shows it is requiredrequired
17Personnel shall wear protective clothingwork clothing requiredwork clothing requiredrequiredcomplete change required before exit and entry
18Written procedures and records of staff trainingnot requiredrequired where and to extent the risk assessment shows they are requiredrequiredrequired
Waste
19Inactivation of GMMs in effluent from hand-washing sinks and showers or similar effluentsnot requirednot requiredrequired where and to extent the risk assessment shows it is requiredrequired
20Inactivation of GMMs in contaminated material and waste including those in process effluent before final dischargerequired by validated means where and to extent the risk assessment shows it to be requiredrequired by validated meansrequired by validated meansrequired by validated means
(1)

OJ No L262, 17.10.2000, p21

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Rule and provides information about its policy objective and policy implications. They aim to make the Statutory Rule accessible to readers who are not legally qualified and accompany any Northern Ireland Statutory Rule or Draft Northern Ireland Statutory Rule laid before the UK Parliament during the suspension of the Northern Ireland Assembly.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources